Your browser doesn't support javascript.
loading
Brigatinib Versus Crizotinib in ALK Inhibitor-Naive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial.
Camidge, D Ross; Kim, Hye Ryun; Ahn, Myung-Ju; Yang, James C H; Han, Ji-Youn; Hochmair, Maximilian J; Lee, Ki Hyeong; Delmonte, Angelo; Garcia Campelo, Maria Rosario; Kim, Dong-Wan; Griesinger, Frank; Felip, Enriqueta; Califano, Raffaele; Spira, Alexander I; Gettinger, Scott N; Tiseo, Marcello; Lin, Huamao M; Liu, Yuyin; Vranceanu, Florin; Niu, Huifeng; Zhang, Pingkuan; Popat, Sanjay.
Afiliación
  • Camidge DR; Department of Medicine, University of Colorado Cancer Center, Aurora, Colorado. Electronic address: ross.camidge@cuanschutz.edu.
  • Kim HR; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
  • Ahn MJ; Division of Hematology-Oncology, Samsung Medical Center, Seoul, South Korea.
  • Yang JCH; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.
  • Han JY; Department of Precision Medicine, National Cancer Center, Gyeonggi, South Korea.
  • Hochmair MJ; Department of Respiratory and Critical Care Medicine, Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Vienna, Austria.
  • Lee KH; Internal Medicine Department, Chungbuk National University Hospital, Chungbuk, South Korea.
  • Delmonte A; Department of Medical Oncology, Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" (IRST) Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Meldola, Italy.
  • Garcia Campelo MR; Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña (CHUAC), University Hospital A Coruña, A Coruña, Spain.
  • Kim DW; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.
  • Griesinger F; Department of Hematology and Oncology, Pius-Hospital Oldenburg, University of Oldenburg, Oldenburg, Germany.
  • Felip E; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Califano R; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom; Department of Medical Oncology, Division of Cancer Sciences, The University of Manchester, Manchester, England, United Kingdom.
  • Spira AI; Department of Medical Oncology, Virginia Cancer Specialists, US Oncology Research, Fairfax, Virginia.
  • Gettinger SN; Department of Medical Oncology, Yale Cancer Center, New Haven, Connecticut.
  • Tiseo M; Department of Medicine and Surgery, University Hospital of Parma, Parma, Italy.
  • Lin HM; Global Evidence and Outcome, Millennium Pharmaceuticals, Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts.
  • Liu Y; Oncology Statistics, Millennium Pharmaceuticals, Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts.
  • Vranceanu F; Clinical Science, Millennium Pharmaceuticals, Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts.
  • Niu H; Oncology Translational Sciences, Millennium Pharmaceuticals, Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts.
  • Zhang P; Oncology Clinical Research, Millennium Pharmaceuticals, Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts.
  • Popat S; Royal Marsden Hospital, London, United Kingdom.
J Thorac Oncol ; 16(12): 2091-2108, 2021 12.
Article en En | MEDLINE | ID: mdl-34537440
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pulmonares Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Thorac Oncol Año: 2021 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pulmonares Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Thorac Oncol Año: 2021 Tipo del documento: Article